Vivos Therapeutics, Inc. cotiza a 0.14 USD y tiene una capitalización bursátil de $5M. En los últimos 12 meses ha facturado $21M con un margen de flujo de caja libre del -100.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical,…
| Periodo | 2026-08 | 2026-05 | 2026-04 | 2026-04 |
|---|---|---|---|---|
| Real | — | $-0.52 | $-0.58 | — |
| Estimado | $-0.39 | $-0.45 | $-0.48 | $-0.48 |
| Sorpresa | — | -15.6% | -20.8% | — |
| Métrica | VVOS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 60.4% | 57.0% | +3.4% |
| Operating Margin | -114.0% | -38.6% | -75.4% |
| Net Margin | -121.4% | -33.6% | -87.8% |
| FCF Margin | -100.9% | -13.9% | -87.1% |
| ROE | — | -40.4% | — |
| ROA | -84.2% | -32.0% | -52.2% |
| Current Ratio | 0.24 | 2.84 | -2.60 |
| Debt / Equity | -0.51 | 0.28 | -0.79 |